Cargando…

Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years

BACKGROUND: Stereotactic body radiotherapy (SBRT) may yield disease control for prostate cancer in a brief, hypofractionated treatment regimen without increasing treatment toxicity. Our report presents a 6-year update from 304 low- (n = 211), intermediate- (n = 81), and high-risk (n = 12) prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katz, Alan J, Santoro, Michael, Diblasio, Fred, Ashley, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674983/ https://www.ncbi.nlm.nih.gov/pubmed/23668632 http://dx.doi.org/10.1186/1748-717X-8-118

Ejemplares similares

Stereotactic body radiotherapy for organ-confined prostate cancer
por: Katz, Alan J, et al.
Publicado: (2010)

Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
por: Katz, Alan J., et al.
Publicado: (2011)

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
por: Katz, Alan, et al.
Publicado: (2012)

Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis
por: Katz, Alan
Publicado: (2017)

Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
por: Vuolukka, Kristiina, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study
por: Katz, Alan Jay, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
por: Katz, Alan, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure
por: Katz, Alan, et al.
Publicado: (2016)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
por: Pepin, Abigail N., et al.
Publicado: (2022)

Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
por: Freeman, Debra E, et al.
Publicado: (2011)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer
por: Lin, Yu-Wei, et al.
Publicado: (2014)

Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
por: Krug, David, et al.
Publicado: (2023)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
por: Kim, Hun Jung, et al.
Publicado: (2015)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultrahypofractionated Stereotactic Body Radiotherapy
por: Milecki, Piotr, et al.
Publicado: (2023)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
por: Kawakami, S., et al.
Publicado: (2022)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment
por: Rucinska, Monika, et al.
Publicado: (2016)

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
por: Kishan, Amar U., et al.
Publicado: (2019)

Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer
por: Boyer, Matthew J., et al.
Publicado: (2017)

A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy
por: Bolzicco, Giampaolo, et al.
Publicado: (2013)

Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
por: Hwang, Mark E., et al.
Publicado: (2019)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing
por: Greco, Carlo, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review
por: Foerster, Robert, et al.
Publicado: (2021)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Stereotactic IMRT for prostate cancer: Setup accuracy of a new stereotactic body localization system
por: Wang, Lu, et al.
Publicado: (2004)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
por: Gutkin, Paulina M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_unip1i79bhsui674a5a5t2m9ql